# FDA Inspection 1260553 - Nathalie Daaboul - January 24, 2025

Source: https://www.keypedia.com/records/fda_inspections/nathalie-daaboul/866e3c34-2cf4-4a00-830e-fdea96c2bed9
Source feed: FDA_Inspections

> FDA Inspection 1260553 for Nathalie Daaboul on January 24, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260553
- Company Name: Nathalie Daaboul
- Inspection Date: 2025-01-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1260553 - 2025-01-24](https://www.keypedia.com/records/fda_inspections/nathalie-daaboul/2c33401f-6c5b-4e2d-957a-f02ea075070a)

Company: https://www.keypedia.com/companies/nathalie-daaboul/f3ea0fc8-0b23-46f2-8634-e33a82898d56

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c